Position in TNGX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$6,843,851
+$2,608,224 QoQ
Shares Held
327,144
-31.6% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 79.34090186584501.ToString("F0")%
Shared 0.ToString("F0")%
None 20.65909813415499.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. TNGX ranks #120 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in TNGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,843,851 | 327,144 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,235,627 | 478,062 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,305,752 | 155,447 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $241,380 | 47,145 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $481,538 | 351,489 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $841,198 | 272,233 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,350,340 | 175,369 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $702,701 | 81,900 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $857,861 | 108,043 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $591,979 | 59,796 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $585,022 | 51,956 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $215,915 | 65,035 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $394,079 | 99,767 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,068,505 | 147,380 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $348,091 | 96,158 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $364,410 | 80,444 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $605,649 | 79,901 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,027,024 | 93,878 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $387 | 30 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||